Skip to main content
Top
Published in: Medical Molecular Morphology 4/2016

01-12-2016 | Review

Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma

Authors: Hiep Nguyen Canh, Kenichi Harada

Published in: Medical Molecular Morphology | Issue 4/2016

Login to get access

Abstract

Biliary epithelial cells preferentially respond to various insults under chronic pathological conditions leading to reactively atypical changes, hyperplasia, or the development of biliary neoplasms (such as biliary intraepithelial neoplasia, intraductal papillary neoplasm of the bile duct, and cholangiocarcinoma). Moreover, benign biliary strictures can be caused by a variety of disorders (such as IgG4-related sclerosing cholangitis, eosinophilic cholangitis, and follicular cholangitis) and often mimic malignancies, despite their benign nature. In addition, primary sclerosing cholangitis is a well-characterized precursor lesion of cholangiocarcinoma and many other chronic inflammatory disorders increase the risk of malignancies. Because of these factors and the changes in biliary epithelial cells, biliary strictures frequently pose a diagnostic challenge. Although the ability to differentiate neoplastic from non-neoplastic biliary strictures has markedly progressed with the advance in radiological modalities, brush cytology and bile duct biopsy examination remains effective. However, no single modality is adequate to diagnose benign biliary strictures because of the low sensitivity. Therefore, understanding the underlying causes by compiling the entire clinical, laboratory, and imaging data; considering the under-recognized causes; and collaborating between experts in various fields including cytopathologists with multiple approaches is necessary to achieve an accurate diagnosis.
Literature
1.
go back to reference Bowlus CL, Olson KA, Gershwin ME (2016) Evaluation of indeterminate biliary strictures. Nat Rev Gastroenterol Hepatol 13(1):28–37PubMedCrossRef Bowlus CL, Olson KA, Gershwin ME (2016) Evaluation of indeterminate biliary strictures. Nat Rev Gastroenterol Hepatol 13(1):28–37PubMedCrossRef
2.
go back to reference Katabathina VS, Dasyam AK, Dasyam N, Hosseinzadeh K (2014) Adult bile duct strictures: role of MR imaging and MR cholangiopancreatography in characterization. Radiographics 34(3):565–586PubMedCrossRef Katabathina VS, Dasyam AK, Dasyam N, Hosseinzadeh K (2014) Adult bile duct strictures: role of MR imaging and MR cholangiopancreatography in characterization. Radiographics 34(3):565–586PubMedCrossRef
4.
5.
go back to reference Lee JY, Lim JH, Lim HK (2005) Follicular cholangitis mimicking hilar cholangiocarcinoma. Abdom Imaging 30(6):744–747PubMedCrossRef Lee JY, Lim JH, Lim HK (2005) Follicular cholangitis mimicking hilar cholangiocarcinoma. Abdom Imaging 30(6):744–747PubMedCrossRef
6.
go back to reference Zepeda-Gomez S, Baron TH (2011) Benign biliary strictures: current endoscopic management. Nat Rev Gastroenterol Hepatol 8(10):573–581PubMedCrossRef Zepeda-Gomez S, Baron TH (2011) Benign biliary strictures: current endoscopic management. Nat Rev Gastroenterol Hepatol 8(10):573–581PubMedCrossRef
7.
go back to reference Kaffes AJ (2015) Management of benign biliary strictures: current status and perspective. J Hepatobiliary Pancreat Sci 22(9):657–663PubMedCrossRef Kaffes AJ (2015) Management of benign biliary strictures: current status and perspective. J Hepatobiliary Pancreat Sci 22(9):657–663PubMedCrossRef
8.
go back to reference Navaneethan U, Njei B, Lourdusamy V, Konjeti R, Vargo JJ, Parsi MA (2015) Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc 81(1):168–176PubMedCrossRef Navaneethan U, Njei B, Lourdusamy V, Konjeti R, Vargo JJ, Parsi MA (2015) Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc 81(1):168–176PubMedCrossRef
9.
go back to reference Nanda A, Brown JM, Berger SH, Lewis MM, Barr Fritcher EG, Gores GJ, Keilin SA, Woods KE, Cai Q, Willingham FF (2015) Triple modality testing by endoscopic retrograde cholangiopancreatography for the diagnosis of cholangiocarcinoma. Therap Adv Gastroenterol 8(2):56–65PubMedPubMedCentralCrossRef Nanda A, Brown JM, Berger SH, Lewis MM, Barr Fritcher EG, Gores GJ, Keilin SA, Woods KE, Cai Q, Willingham FF (2015) Triple modality testing by endoscopic retrograde cholangiopancreatography for the diagnosis of cholangiocarcinoma. Therap Adv Gastroenterol 8(2):56–65PubMedPubMedCentralCrossRef
10.
go back to reference Sadeghi A, Mohamadnejad M, Islami F, Keshtkar A, Biglari M, Malekzadeh R, Eloubeidi MA (2016) Diagnostic yield of EUS-guided FNA for malignant biliary stricture: a systematic review and meta-analysis. Gastrointest Endosc 83(2):290–298 (e1) PubMedCrossRef Sadeghi A, Mohamadnejad M, Islami F, Keshtkar A, Biglari M, Malekzadeh R, Eloubeidi MA (2016) Diagnostic yield of EUS-guided FNA for malignant biliary stricture: a systematic review and meta-analysis. Gastrointest Endosc 83(2):290–298 (e1) PubMedCrossRef
11.
go back to reference Navaneethan U, Hasan MK, Lourdusamy V, Njei B, Varadarajulu S, Hawes RH (2015) Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review. Gastrointest Endosc 82(4):608–614PubMedPubMedCentralCrossRef Navaneethan U, Hasan MK, Lourdusamy V, Njei B, Varadarajulu S, Hawes RH (2015) Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review. Gastrointest Endosc 82(4):608–614PubMedPubMedCentralCrossRef
12.
go back to reference Fujita T, Kojima M, Kato Y, Gotohda N, Takahashi S, Konishi M, Kinoshita T (2010) Clinical and histopathological study of “follicular cholangitis”: sclerosing cholangitis with prominent lymphocytic infiltration masquerading as hilar cholangiocarcinoma. Hepatol Res 40(12):1239–1247PubMedCrossRef Fujita T, Kojima M, Kato Y, Gotohda N, Takahashi S, Konishi M, Kinoshita T (2010) Clinical and histopathological study of “follicular cholangitis”: sclerosing cholangitis with prominent lymphocytic infiltration masquerading as hilar cholangiocarcinoma. Hepatol Res 40(12):1239–1247PubMedCrossRef
13.
go back to reference Wakai T, Shirai Y, Sakata J, Maruyama T, Ohashi T, Korira PV, Ajioka Y, Hatakeyama K (2012) Clinicopathological features of benign biliary strictures masquerading as biliary malignancy. Am Surg 78(12):1388–1391PubMed Wakai T, Shirai Y, Sakata J, Maruyama T, Ohashi T, Korira PV, Ajioka Y, Hatakeyama K (2012) Clinicopathological features of benign biliary strictures masquerading as biliary malignancy. Am Surg 78(12):1388–1391PubMed
14.
go back to reference de Vries AB, Janse M, Blokzijl H, Weersma RK (2015) Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol 21(6):1956–1971PubMedPubMedCentralCrossRef de Vries AB, Janse M, Blokzijl H, Weersma RK (2015) Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol 21(6):1956–1971PubMedPubMedCentralCrossRef
15.
go back to reference Sano H, Nakazawa T, Ando T, Hayashi K, Naitoh I, Okumura F, Miyabe K, Yoshida M, Takahashi S, Ohara H, Joh T (2011) Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis. J Hepatobiliary Pancreat Sci 18(2):154–161PubMedCrossRef Sano H, Nakazawa T, Ando T, Hayashi K, Naitoh I, Okumura F, Miyabe K, Yoshida M, Takahashi S, Ohara H, Joh T (2011) Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis. J Hepatobiliary Pancreat Sci 18(2):154–161PubMedCrossRef
16.
go back to reference Aadland E, Schrumpf E, Fausa O, Elgjo K, Heilo A, Aakhus T, Gjone E (1987) Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 22(6):655–664PubMedCrossRef Aadland E, Schrumpf E, Fausa O, Elgjo K, Heilo A, Aakhus T, Gjone E (1987) Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 22(6):655–664PubMedCrossRef
17.
go back to reference Nakazawa T, Naitoh I, Hayashi K, Sano H, Miyabe K, Shimizu S, Joh T (2014) Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity? World J Gastroenterol 20(12):3245–3254PubMedPubMedCentralCrossRef Nakazawa T, Naitoh I, Hayashi K, Sano H, Miyabe K, Shimizu S, Joh T (2014) Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity? World J Gastroenterol 20(12):3245–3254PubMedPubMedCentralCrossRef
18.
go back to reference Tanaka A, Takikawa H (2013) Geoepidemiology of primary sclerosing cholangitis: a critical review. J Autoimmun 46:35–40PubMedCrossRef Tanaka A, Takikawa H (2013) Geoepidemiology of primary sclerosing cholangitis: a critical review. J Autoimmun 46:35–40PubMedCrossRef
19.
go back to reference Weismüller TJ, Talwalkar JA, Ponsioen CY, Gotthardt DN, Marschall HU, Naess S, Holm K, Weersma RK, Lazaridis KN, Fevery J, Trivedi PJ, Schramm C, Chazouilleres O, Müller T, Farkkila M, Almer S, Pereira S, Mason AL, Floreani A, Milkiewicz P, Harley H, Pares A, de Vries L, Manser C, Gatselis N, Berg C, Lenzen H, de Valle MB, Imam M, Kirchner G, de Leuw P, Zimmer V, Fabris L, Braun F, Hirschfield GM, Marzioni M, Juran BD, Strassburg CP, Beuers U, Manns MP, Schrumpf E, Karlsen TH, Bergquist A, Boberg KM (2014) Primary sclerosing cholangitis from a global perspective—a multicenter, retrospective, observational study of the international PSC study group. J Hepatol 60(1, Supplement):S3 Weismüller TJ, Talwalkar JA, Ponsioen CY, Gotthardt DN, Marschall HU, Naess S, Holm K, Weersma RK, Lazaridis KN, Fevery J, Trivedi PJ, Schramm C, Chazouilleres O, Müller T, Farkkila M, Almer S, Pereira S, Mason AL, Floreani A, Milkiewicz P, Harley H, Pares A, de Vries L, Manser C, Gatselis N, Berg C, Lenzen H, de Valle MB, Imam M, Kirchner G, de Leuw P, Zimmer V, Fabris L, Braun F, Hirschfield GM, Marzioni M, Juran BD, Strassburg CP, Beuers U, Manns MP, Schrumpf E, Karlsen TH, Bergquist A, Boberg KM (2014) Primary sclerosing cholangitis from a global perspective—a multicenter, retrospective, observational study of the international PSC study group. J Hepatol 60(1, Supplement):S3
20.
go back to reference Tanaka A, Tazuma S, Okazaki K, Tsubouchi H, Inui K, Takikawa H (2014) Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan. J Hepatobiliary Pancreat Sci 21(1):43–50PubMedCrossRef Tanaka A, Tazuma S, Okazaki K, Tsubouchi H, Inui K, Takikawa H (2014) Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan. J Hepatobiliary Pancreat Sci 21(1):43–50PubMedCrossRef
21.
go back to reference Tanaka A, Tazuma S, Okazaki K, Tsubouchi H, Inui K, Takikawa H (2015) Clinical profiles of patients with primary sclerosing cholangitis in the elderly. J Hepatobiliary Pancreat Sci 22(3):230–236PubMedCrossRef Tanaka A, Tazuma S, Okazaki K, Tsubouchi H, Inui K, Takikawa H (2015) Clinical profiles of patients with primary sclerosing cholangitis in the elderly. J Hepatobiliary Pancreat Sci 22(3):230–236PubMedCrossRef
22.
go back to reference Yimam KK, Bowlus CL (2014) Diagnosis and classification of primary sclerosing cholangitis. Autoimmun Rev 13(4–5):445–450PubMedCrossRef Yimam KK, Bowlus CL (2014) Diagnosis and classification of primary sclerosing cholangitis. Autoimmun Rev 13(4–5):445–450PubMedCrossRef
23.
go back to reference Lindor KD, Kowdley KV, Harrison ME, American College of G (2015) ACG clinical guideline: primary sclerosing cholangitis. Am J Gastroenterol 110(5):646–659 (quiz 660) PubMedCrossRef Lindor KD, Kowdley KV, Harrison ME, American College of G (2015) ACG clinical guideline: primary sclerosing cholangitis. Am J Gastroenterol 110(5):646–659 (quiz 660) PubMedCrossRef
24.
go back to reference Hirschfield GM, Karlsen TH, Lindor KD, Adams DH (2013) Primary sclerosing cholangitis. The Lancet 382(9904):1587–1599CrossRef Hirschfield GM, Karlsen TH, Lindor KD, Adams DH (2013) Primary sclerosing cholangitis. The Lancet 382(9904):1587–1599CrossRef
25.
go back to reference Angulo P, Maor-Kendler Y, Lindor KD (2002) Small-duct primary sclerosing cholangitis: a long-term follow-up study. Hepatology 35(6):1494–1500PubMedCrossRef Angulo P, Maor-Kendler Y, Lindor KD (2002) Small-duct primary sclerosing cholangitis: a long-term follow-up study. Hepatology 35(6):1494–1500PubMedCrossRef
26.
go back to reference Kaplan GG, Laupland KB, Butzner D, Urbanski SJ, Lee SS (2007) The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol 102(5):1042–1049PubMedCrossRef Kaplan GG, Laupland KB, Butzner D, Urbanski SJ, Lee SS (2007) The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol 102(5):1042–1049PubMedCrossRef
27.
go back to reference Mieli-Vergani G, Vergani D (2016) Sclerosing cholangitis in children and adolescents. Clin Liver Dis 20(1):99–111PubMedCrossRef Mieli-Vergani G, Vergani D (2016) Sclerosing cholangitis in children and adolescents. Clin Liver Dis 20(1):99–111PubMedCrossRef
28.
go back to reference Sarkar S, Bowlus CL (2016) Primary sclerosing cholangitis: multiple phenotypes, multiple approaches. Clin Liver Dis 20(1):67–77PubMedCrossRef Sarkar S, Bowlus CL (2016) Primary sclerosing cholangitis: multiple phenotypes, multiple approaches. Clin Liver Dis 20(1):67–77PubMedCrossRef
29.
go back to reference Berntsen NL, Klingenberg O, Juran BD, Benito de Valle M, Lindkvist B, Lazaridis KN, Boberg KM, Karlsen TH, Hov JR (2015) Association between HLA haplotypes and increased serum levels of IgG4 in patients with primary sclerosing cholangitis. Gastroenterology 148(5):924–927 (e2) Berntsen NL, Klingenberg O, Juran BD, Benito de Valle M, Lindkvist B, Lazaridis KN, Boberg KM, Karlsen TH, Hov JR (2015) Association between HLA haplotypes and increased serum levels of IgG4 in patients with primary sclerosing cholangitis. Gastroenterology 148(5):924–927 (e2)
30.
go back to reference Matsubayashi H, Igarashi K, Kishida Y, Yoshida Y, Sasaki K, Ono H (2014) Sclerosing cholangitis with thumbprint appearance and incomplete steroid response. J Dig Dis 15(10):578–582PubMedCrossRef Matsubayashi H, Igarashi K, Kishida Y, Yoshida Y, Sasaki K, Ono H (2014) Sclerosing cholangitis with thumbprint appearance and incomplete steroid response. J Dig Dis 15(10):578–582PubMedCrossRef
31.
go back to reference Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, Andreassen OA, Weersma RK, Weismuller TJ, Eksteen B, Invernizzi P, Hirschfield GM, Gotthardt DN, Pares A, Ellinghaus D, Shah T, Juran BD, Milkiewicz P, Rust C, Schramm C, Muller T, Srivastava B, Dalekos G, Nothen MM, Herms S, Winkelmann J, Mitrovic M, Braun F, Ponsioen CY, Croucher PJ, Sterneck M, Teufel A, Mason AL, Saarela J, Leppa V, Dorfman R, Alvaro D, Floreani A, Onengut-Gumuscu S, Rich SS, Thompson WK, Schork AJ, Naess S, Thomsen I, Mayr G, Konig IR, Hveem K, Cleynen I, Gutierrez-Achury J, Ricano-Ponce I, van Heel D, Bjornsson E, Sandford RN, Durie PR, Melum E, Vatn MH, Silverberg MS, Duerr RH, Padyukov L, Brand S, Sans M, Annese V, Achkar JP, Boberg KM, Marschall HU, Chazouilleres O, Bowlus CL, Wijmenga C, Schrumpf E, Vermeire S, Albrecht M, Consortium U-P, Rioux JD, Alexander G, Bergquist A, Cho J, Schreiber S, Manns MP, Farkkila M, Dale AM, Chapman RW, Lazaridis KN, International PSCSG, Franke A, Anderson CA, Karlsen TH, International IBDGC (2013) Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet 45(6):670–675 Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, Andreassen OA, Weersma RK, Weismuller TJ, Eksteen B, Invernizzi P, Hirschfield GM, Gotthardt DN, Pares A, Ellinghaus D, Shah T, Juran BD, Milkiewicz P, Rust C, Schramm C, Muller T, Srivastava B, Dalekos G, Nothen MM, Herms S, Winkelmann J, Mitrovic M, Braun F, Ponsioen CY, Croucher PJ, Sterneck M, Teufel A, Mason AL, Saarela J, Leppa V, Dorfman R, Alvaro D, Floreani A, Onengut-Gumuscu S, Rich SS, Thompson WK, Schork AJ, Naess S, Thomsen I, Mayr G, Konig IR, Hveem K, Cleynen I, Gutierrez-Achury J, Ricano-Ponce I, van Heel D, Bjornsson E, Sandford RN, Durie PR, Melum E, Vatn MH, Silverberg MS, Duerr RH, Padyukov L, Brand S, Sans M, Annese V, Achkar JP, Boberg KM, Marschall HU, Chazouilleres O, Bowlus CL, Wijmenga C, Schrumpf E, Vermeire S, Albrecht M, Consortium U-P, Rioux JD, Alexander G, Bergquist A, Cho J, Schreiber S, Manns MP, Farkkila M, Dale AM, Chapman RW, Lazaridis KN, International PSCSG, Franke A, Anderson CA, Karlsen TH, International IBDGC (2013) Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet 45(6):670–675
32.
go back to reference Nakanuma Y, Sasaki M, Harada K (2015) Autophagy and senescence in fibrosing cholangiopathies. J Hepatol 62(4):934–945PubMedCrossRef Nakanuma Y, Sasaki M, Harada K (2015) Autophagy and senescence in fibrosing cholangiopathies. J Hepatol 62(4):934–945PubMedCrossRef
34.
go back to reference Naitoh I, Zen Y, Nakazawa T, Ando T, Hayashi K, Okumura F, Miyabe K, Yoshida M, Nojiri S, Kanematsu T, Ohara H, Joh T (2011) Small bile duct involvement in IgG4-related sclerosing cholangitis: liver biopsy and cholangiography correlation. J Gastroenterol 46(2):269–276PubMedCrossRef Naitoh I, Zen Y, Nakazawa T, Ando T, Hayashi K, Okumura F, Miyabe K, Yoshida M, Nojiri S, Kanematsu T, Ohara H, Joh T (2011) Small bile duct involvement in IgG4-related sclerosing cholangitis: liver biopsy and cholangiography correlation. J Gastroenterol 46(2):269–276PubMedCrossRef
35.
go back to reference Deshpande V, Sainani NI, Chung RT, Pratt DS, Mentha G, Rubbia-Brandt L, Lauwers GY (2009) IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material. Mod Pathol 22(10):1287–1295PubMedCrossRef Deshpande V, Sainani NI, Chung RT, Pratt DS, Mentha G, Rubbia-Brandt L, Lauwers GY (2009) IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material. Mod Pathol 22(10):1287–1295PubMedCrossRef
36.
go back to reference Folseraas T, Boberg KM (2016) Cancer risk and surveillance in primary sclerosing cholangitis. Clin Liver Dis 20(1):79–98PubMedCrossRef Folseraas T, Boberg KM (2016) Cancer risk and surveillance in primary sclerosing cholangitis. Clin Liver Dis 20(1):79–98PubMedCrossRef
37.
go back to reference Trikudanathan G, Navaneethan U, Njei B, Vargo JJ, Parsi MA (2014) Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. Gastrointest Endosc 79(5):783–789PubMedCrossRef Trikudanathan G, Navaneethan U, Njei B, Vargo JJ, Parsi MA (2014) Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. Gastrointest Endosc 79(5):783–789PubMedCrossRef
38.
go back to reference Navaneethan U, Njei B, Venkatesh PG, Vargo JJ, Parsi MA (2014) Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. Gastrointest Endosc 79(6): 943–950 (e3) Navaneethan U, Njei B, Venkatesh PG, Vargo JJ, Parsi MA (2014) Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. Gastrointest Endosc 79(6): 943–950 (e3)
39.
go back to reference Benito de Valle M, Muller T, Bjornsson E, Otten M, Volkmann M, Guckelberger O, Wiedenmann B, Sadik R, Schott E, Andersson M, Berg T, Lindkvist B (2014) The impact of elevated serum IgG4 levels in patients with primary sclerosing cholangitis. Dig Liver Dis 46(10):903–908PubMedCrossRef Benito de Valle M, Muller T, Bjornsson E, Otten M, Volkmann M, Guckelberger O, Wiedenmann B, Sadik R, Schott E, Andersson M, Berg T, Lindkvist B (2014) The impact of elevated serum IgG4 levels in patients with primary sclerosing cholangitis. Dig Liver Dis 46(10):903–908PubMedCrossRef
40.
go back to reference Mendes FD, Jorgensen R, Keach J, Katzmann JA, Smyrk T, Donlinger J, Chari S, Lindor KD (2006) Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 101(9):2070–2075PubMedCrossRef Mendes FD, Jorgensen R, Keach J, Katzmann JA, Smyrk T, Donlinger J, Chari S, Lindor KD (2006) Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 101(9):2070–2075PubMedCrossRef
41.
go back to reference Zhang L, Lewis JT, Abraham SC, Smyrk TC, Leung S, Chari ST, Poterucha JJ, Rosen CB, Lohse CM, Katzmann JA, Wu TT (2010) IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis. Am J Surg Pathol 34(1):88–94PubMedCrossRef Zhang L, Lewis JT, Abraham SC, Smyrk TC, Leung S, Chari ST, Poterucha JJ, Rosen CB, Lohse CM, Katzmann JA, Wu TT (2010) IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis. Am J Surg Pathol 34(1):88–94PubMedCrossRef
42.
go back to reference Navaneethan U, Venkatesh PG, Choudhary M, Shen B, Kiran RP (2013) Elevated immunoglobulin G4 level is associated with reduced colectomy-free survival in patients with primary sclerosing cholangitis and ulcerative colitis. J Crohns Colitis 7(2):e35–e41PubMedCrossRef Navaneethan U, Venkatesh PG, Choudhary M, Shen B, Kiran RP (2013) Elevated immunoglobulin G4 level is associated with reduced colectomy-free survival in patients with primary sclerosing cholangitis and ulcerative colitis. J Crohns Colitis 7(2):e35–e41PubMedCrossRef
43.
go back to reference Zen Y, Quaglia A, Portmann B (2011) Immunoglobulin G4-positive plasma cell infiltration in explanted livers for primary sclerosing cholangitis. Histopathology 58(3):414–422PubMedCrossRef Zen Y, Quaglia A, Portmann B (2011) Immunoglobulin G4-positive plasma cell infiltration in explanted livers for primary sclerosing cholangitis. Histopathology 58(3):414–422PubMedCrossRef
44.
go back to reference Fischer S, Trivedi PJ, Ward S, Greig PD, Therapondos G, Hirschfield GM (2014) Frequency and significance of IgG4 immunohistochemical staining in liver explants from patients with primary sclerosing cholangitis. Int J Exp Pathol 95(3):209–215PubMedPubMedCentralCrossRef Fischer S, Trivedi PJ, Ward S, Greig PD, Therapondos G, Hirschfield GM (2014) Frequency and significance of IgG4 immunohistochemical staining in liver explants from patients with primary sclerosing cholangitis. Int J Exp Pathol 95(3):209–215PubMedPubMedCentralCrossRef
45.
go back to reference Ohara H, Okazaki K, Tsubouchi H, Inui K, Kawa S, Kamisawa T, Tazuma S, Uchida K, Hirano K, Yoshida H, Nishino T, Ko SB, Mizuno N, Hamano H, Kanno A, Notohara K, Hasebe O, Nakazawa T, Nakanuma Y, Takikawa H, Research Committee of Ig GrD, Research Committee of Intractable Diseases of L, Biliary T, Ministry of Health L, Welfare J, Japan Biliary A (2012) Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci 19(5):536–542 Ohara H, Okazaki K, Tsubouchi H, Inui K, Kawa S, Kamisawa T, Tazuma S, Uchida K, Hirano K, Yoshida H, Nishino T, Ko SB, Mizuno N, Hamano H, Kanno A, Notohara K, Hasebe O, Nakazawa T, Nakanuma Y, Takikawa H, Research Committee of Ig GrD, Research Committee of Intractable Diseases of L, Biliary T, Ministry of Health L, Welfare J, Japan Biliary A (2012) Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci 19(5):536–542
46.
go back to reference Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, Kloppel G, Heathcote JG, Khosroshahi A, Ferry JA, Aalberse RC, Bloch DB, Brugge WR, Bateman AC, Carruthers MN, Chari ST, Cheuk W, Cornell LD, Fernandez-Del Castillo C, Forcione DG, Hamilos DL, Kamisawa T, Kasashima S, Kawa S, Kawano M, Lauwers GY, Masaki Y, Nakanuma Y, Notohara K, Okazaki K, Ryu JK, Saeki T, Sahani DV, Smyrk TC, Stone JR, Takahira M, Webster GJ, Yamamoto M, Zamboni G, Umehara H, Stone JH (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25(9):1181–1192PubMedCrossRef Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, Kloppel G, Heathcote JG, Khosroshahi A, Ferry JA, Aalberse RC, Bloch DB, Brugge WR, Bateman AC, Carruthers MN, Chari ST, Cheuk W, Cornell LD, Fernandez-Del Castillo C, Forcione DG, Hamilos DL, Kamisawa T, Kasashima S, Kawa S, Kawano M, Lauwers GY, Masaki Y, Nakanuma Y, Notohara K, Okazaki K, Ryu JK, Saeki T, Sahani DV, Smyrk TC, Stone JR, Takahira M, Webster GJ, Yamamoto M, Zamboni G, Umehara H, Stone JH (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25(9):1181–1192PubMedCrossRef
47.
48.
go back to reference Brito-Zeron P, Ramos-Casals M, Bosch X, Stone JH (2014) The clinical spectrum of IgG4-related disease. Autoimmun Rev 13(12):1203–1210PubMedCrossRef Brito-Zeron P, Ramos-Casals M, Bosch X, Stone JH (2014) The clinical spectrum of IgG4-related disease. Autoimmun Rev 13(12):1203–1210PubMedCrossRef
49.
go back to reference Inoue D, Yoshida K, Yoneda N, Ozaki K, Matsubara T, Nagai K, Okumura K, Toshima F, Toyama J, Minami T, Matsui O, Gabata T, Zen Y (2015) IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore) 94(15):e680CrossRef Inoue D, Yoshida K, Yoneda N, Ozaki K, Matsubara T, Nagai K, Okumura K, Toshima F, Toyama J, Minami T, Matsui O, Gabata T, Zen Y (2015) IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore) 94(15):e680CrossRef
50.
go back to reference Zen Y, Kawakami H, Kim JH (2016) IgG4-related sclerosing cholangitis: all we need to know. J Gastroenterol 51(4):295–312PubMedCrossRef Zen Y, Kawakami H, Kim JH (2016) IgG4-related sclerosing cholangitis: all we need to know. J Gastroenterol 51(4):295–312PubMedCrossRef
51.
go back to reference Nakazawa T, Naitoh I, Hayashi K, Miyabe K, Simizu S, Joh T (2013) Diagnosis of IgG4-related sclerosing cholangitis. World J Gastroenterol 19(43):7661–7670PubMedPubMedCentralCrossRef Nakazawa T, Naitoh I, Hayashi K, Miyabe K, Simizu S, Joh T (2013) Diagnosis of IgG4-related sclerosing cholangitis. World J Gastroenterol 19(43):7661–7670PubMedPubMedCentralCrossRef
52.
go back to reference Nakazawa T, Ikeda Y, Kawaguchi Y, Kitagawa H, Takada H, Takeda Y, Makino I, Makino N, Naitoh I, Tanaka A (2015) Isolated intrapancreatic IgG4-related sclerosing cholangitis. World J Gastroenterol 21(4):1334–1343PubMedPubMedCentralCrossRef Nakazawa T, Ikeda Y, Kawaguchi Y, Kitagawa H, Takada H, Takeda Y, Makino I, Makino N, Naitoh I, Tanaka A (2015) Isolated intrapancreatic IgG4-related sclerosing cholangitis. World J Gastroenterol 21(4):1334–1343PubMedPubMedCentralCrossRef
53.
go back to reference Ohara H, Nakazawa T, Kawa S, Kamisawa T, Shimosegawa T, Uchida K, Hirano K, Nishino T, Hamano H, Kanno A, Notohara K, Hasebe O, Muraki T, Ishida E, Naitoh I, Okazaki K (2013) Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related sclerosing cholangitis: a Japanese cohort. J Gastroenterol Hepatol 28(7):1247–1251PubMedCrossRef Ohara H, Nakazawa T, Kawa S, Kamisawa T, Shimosegawa T, Uchida K, Hirano K, Nishino T, Hamano H, Kanno A, Notohara K, Hasebe O, Muraki T, Ishida E, Naitoh I, Okazaki K (2013) Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related sclerosing cholangitis: a Japanese cohort. J Gastroenterol Hepatol 28(7):1247–1251PubMedCrossRef
54.
go back to reference Graham RPD, Smyrk TC, Chari ST, Takahashi N, Zhang L (2014) Isolated IgG4-related sclerosing cholangitis: a report of 9 cases. Hum Pathol 45(8):1722–1729PubMedCrossRef Graham RPD, Smyrk TC, Chari ST, Takahashi N, Zhang L (2014) Isolated IgG4-related sclerosing cholangitis: a report of 9 cases. Hum Pathol 45(8):1722–1729PubMedCrossRef
55.
go back to reference Okazaki K, Uchida K, Koyabu M, Miyoshi H, Ikeura T, Takaoka M (2014) IgG4 cholangiopathy—current concept, diagnosis, and pathogenesis. J Hepatol 61(3):690–695PubMedCrossRef Okazaki K, Uchida K, Koyabu M, Miyoshi H, Ikeura T, Takaoka M (2014) IgG4 cholangiopathy—current concept, diagnosis, and pathogenesis. J Hepatol 61(3):690–695PubMedCrossRef
56.
go back to reference Hart PA, Zen Y, Chari ST (2015) Recent advances in autoimmune pancreatitis. Gastroenterology 149(1):39–51PubMedCrossRef Hart PA, Zen Y, Chari ST (2015) Recent advances in autoimmune pancreatitis. Gastroenterology 149(1):39–51PubMedCrossRef
57.
go back to reference Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, Chari ST, Della-Torre E, Frulloni L, Goto H, Hart PA, Kamisawa T, Kawa S, Kawano M, Kim MH, Kodama Y, Kubota K, Lerch MM, Löhr M, Masaki Y, Matsui S, Mimori T, Nakamura S, Nakazawa T, Ohara H, Okazaki K, Ryu JH, Saeki T, Schleinitz N, Shimatsu A, Shimosegawa T, Takahashi H, Takahira M, Tanaka A, Topazian M, Umehara H, Webster GJ, Witzig TE, Yamamoto M, Zhang W, Chiba T, Stone JH (2015) International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 67(7):1688–1699PubMedCrossRef Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, Chari ST, Della-Torre E, Frulloni L, Goto H, Hart PA, Kamisawa T, Kawa S, Kawano M, Kim MH, Kodama Y, Kubota K, Lerch MM, Löhr M, Masaki Y, Matsui S, Mimori T, Nakamura S, Nakazawa T, Ohara H, Okazaki K, Ryu JH, Saeki T, Schleinitz N, Shimatsu A, Shimosegawa T, Takahashi H, Takahira M, Tanaka A, Topazian M, Umehara H, Webster GJ, Witzig TE, Yamamoto M, Zhang W, Chiba T, Stone JH (2015) International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 67(7):1688–1699PubMedCrossRef
58.
go back to reference Oseini AM, Chaiteerakij R, Shire AM, Ghazale A, Kaiya J, Moser CD, Aderca I, Mettler TA, Therneau TM, Zhang L, Takahashi N, Chari ST, Roberts LR (2011) Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology 54(3):940–948PubMedPubMedCentralCrossRef Oseini AM, Chaiteerakij R, Shire AM, Ghazale A, Kaiya J, Moser CD, Aderca I, Mettler TA, Therneau TM, Zhang L, Takahashi N, Chari ST, Roberts LR (2011) Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology 54(3):940–948PubMedPubMedCentralCrossRef
59.
go back to reference Stone JH, Brito-Zerón P, Bosch X, Ramos-Casals M (2015) Diagnostic approach to the complexity of IgG4-related disease. Mayo Clin Proc 90(7):927–939PubMedCrossRef Stone JH, Brito-Zerón P, Bosch X, Ramos-Casals M (2015) Diagnostic approach to the complexity of IgG4-related disease. Mayo Clin Proc 90(7):927–939PubMedCrossRef
60.
go back to reference Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH (2015) The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis 74(1):14–18PubMedCrossRef Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH (2015) The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis 74(1):14–18PubMedCrossRef
61.
go back to reference Ngwa TN, Law R, Murray D, Chari ST (2014) Serum immunoglobulin G4 level is a poor predictor of immunoglobulin G4-related disease. Pancreas 43(5):704–707PubMedCrossRef Ngwa TN, Law R, Murray D, Chari ST (2014) Serum immunoglobulin G4 level is a poor predictor of immunoglobulin G4-related disease. Pancreas 43(5):704–707PubMedCrossRef
62.
go back to reference Harada K, Shimoda S, Kimura Y, Sato Y, Ikeda H, Igarashi S, Ren XS, Sato H, Nakanuma Y (2012) Significance of immunoglobulin G4 (IgG4)-positive cells in extrahepatic cholangiocarcinoma: molecular mechanism of IgG4 reaction in cancer tissue. Hepatology 56(1):157–164PubMedCrossRef Harada K, Shimoda S, Kimura Y, Sato Y, Ikeda H, Igarashi S, Ren XS, Sato H, Nakanuma Y (2012) Significance of immunoglobulin G4 (IgG4)-positive cells in extrahepatic cholangiocarcinoma: molecular mechanism of IgG4 reaction in cancer tissue. Hepatology 56(1):157–164PubMedCrossRef
63.
go back to reference Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, Stone JH (2015) IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol 67(9):2466–2475PubMedPubMedCentralCrossRef Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, Stone JH (2015) IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol 67(9):2466–2475PubMedPubMedCentralCrossRef
64.
go back to reference Khosroshahi A, Cheryk LA, Carruthers MN, Edwards JA, Bloch DB, Stone JH (2014) Spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease. Arthritis Rheumatol 66(1):213–217PubMedCrossRef Khosroshahi A, Cheryk LA, Carruthers MN, Edwards JA, Bloch DB, Stone JH (2014) Spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease. Arthritis Rheumatol 66(1):213–217PubMedCrossRef
65.
go back to reference Boonstra K, Culver EL, de Buy Wenniger LM, van Heerde MJ, van Erpecum KJ, Poen AC, van Nieuwkerk KM, Spanier BW, Witteman BJ, Tuynman HA, van Geloven N, van Buuren H, Chapman RW, Barnes E, Beuers U, Ponsioen CY (2014) Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology 59(5):1954–1963PubMedPubMedCentralCrossRef Boonstra K, Culver EL, de Buy Wenniger LM, van Heerde MJ, van Erpecum KJ, Poen AC, van Nieuwkerk KM, Spanier BW, Witteman BJ, Tuynman HA, van Geloven N, van Buuren H, Chapman RW, Barnes E, Beuers U, Ponsioen CY (2014) Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology 59(5):1954–1963PubMedPubMedCentralCrossRef
66.
go back to reference Wallace ZS, Mattoo H, Carruthers M, Mahajan VS, Della Torre E, Lee H, Kulikova M, Deshpande V, Pillai S, Stone JH (2015) Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis 74(1):190–195PubMedCrossRef Wallace ZS, Mattoo H, Carruthers M, Mahajan VS, Della Torre E, Lee H, Kulikova M, Deshpande V, Pillai S, Stone JH (2015) Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis 74(1):190–195PubMedCrossRef
67.
go back to reference Mattoo H, Mahajan VS, Della-Torre E, Sekigami Y, Carruthers M, Wallace ZS, Deshpande V, Stone JH, Pillai S (2014) De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol 134(3):679–687PubMedPubMedCentralCrossRef Mattoo H, Mahajan VS, Della-Torre E, Sekigami Y, Carruthers M, Wallace ZS, Deshpande V, Stone JH, Pillai S (2014) De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol 134(3):679–687PubMedPubMedCentralCrossRef
68.
go back to reference Smit WL, Culver EL, Chapman RW (2016) New thoughts on immunoglobulin G4-related sclerosing cholangitis. Clin Liver Dis 20(1):47–65PubMedCrossRef Smit WL, Culver EL, Chapman RW (2016) New thoughts on immunoglobulin G4-related sclerosing cholangitis. Clin Liver Dis 20(1):47–65PubMedCrossRef
69.
go back to reference Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, Haratake J, Kurumaya H, Katayanagi K, Masuda S, Niwa H, Morimoto H, Miwa A, Uchiyama A, Portmann BC, Nakanuma Y (2004) IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 28(9):1193–1203PubMedCrossRef Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, Haratake J, Kurumaya H, Katayanagi K, Masuda S, Niwa H, Morimoto H, Miwa A, Uchiyama A, Portmann BC, Nakanuma Y (2004) IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 28(9):1193–1203PubMedCrossRef
70.
go back to reference Zen Y, Nakanuma Y, Portmann B (2012) Immunoglobulin G4-related sclerosing cholangitis: pathologic features and histologic mimics. Semin Diagn Pathol 29(4):205–211PubMedCrossRef Zen Y, Nakanuma Y, Portmann B (2012) Immunoglobulin G4-related sclerosing cholangitis: pathologic features and histologic mimics. Semin Diagn Pathol 29(4):205–211PubMedCrossRef
72.
go back to reference Huggett MT, Culver EL, Kumar M, Hurst JM, Rodriguez-Justo M, Chapman MH, Johnson GJ, Pereira SP, Chapman RW, Webster GJ, Barnes E (2014) Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. Am J Gastroenterol 109(10):1675–1683PubMedPubMedCentralCrossRef Huggett MT, Culver EL, Kumar M, Hurst JM, Rodriguez-Justo M, Chapman MH, Johnson GJ, Pereira SP, Chapman RW, Webster GJ, Barnes E (2014) Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. Am J Gastroenterol 109(10):1675–1683PubMedPubMedCentralCrossRef
73.
go back to reference Straub BK, Esposito I, Gotthardt D, Radeleff B, Antolovic D, Flechtenmacher C, Schirmacher P (2011) IgG4-associated cholangitis with cholangiocarcinoma. Virchows Arch 458(6):761–765PubMedCrossRef Straub BK, Esposito I, Gotthardt D, Radeleff B, Antolovic D, Flechtenmacher C, Schirmacher P (2011) IgG4-associated cholangitis with cholangiocarcinoma. Virchows Arch 458(6):761–765PubMedCrossRef
74.
go back to reference Oh HC, Kim JG, Kim JW, Lee KS, Kim MK, Chi KC, Kim YS, Kim KH (2008) Early bile duct cancer in a background of sclerosing cholangitis and autoimmune pancreatitis. Intern Med 47(23):2025–2028PubMedCrossRef Oh HC, Kim JG, Kim JW, Lee KS, Kim MK, Chi KC, Kim YS, Kim KH (2008) Early bile duct cancer in a background of sclerosing cholangitis and autoimmune pancreatitis. Intern Med 47(23):2025–2028PubMedCrossRef
75.
go back to reference Ohtani H, Ishida H, Ito Y, Yamaguchi T, Koizumi M (2011) Autoimmune pancreatitis and biliary intraepithelial neoplasia of the common bile duct: a case with diagnostically challenging but pathogenetically significant association. Pathol Int 61(8):481–485PubMedCrossRef Ohtani H, Ishida H, Ito Y, Yamaguchi T, Koizumi M (2011) Autoimmune pancreatitis and biliary intraepithelial neoplasia of the common bile duct: a case with diagnostically challenging but pathogenetically significant association. Pathol Int 61(8):481–485PubMedCrossRef
76.
go back to reference Hart PA, Smyrk TC, Chari ST (2015) Lymphoplasmacytic sclerosing pancreatitis without IgG4 tissue infiltration or serum IgG4 elevation: IgG4-related disease without IgG4. Mod Pathol 28(2):238–247PubMedCrossRef Hart PA, Smyrk TC, Chari ST (2015) Lymphoplasmacytic sclerosing pancreatitis without IgG4 tissue infiltration or serum IgG4 elevation: IgG4-related disease without IgG4. Mod Pathol 28(2):238–247PubMedCrossRef
77.
go back to reference Lin J, Cummings OW, Greenson JK, House MG, Liu X, Nalbantoglu I, Pai R, Davidson DD, Reuss SA (2015) IgG4-related sclerosing cholangitis in the absence of autoimmune pancreatitis mimicking extrahepatic cholangiocarcinoma. Scand J Gastroenterol 50(4):447–453PubMedCrossRef Lin J, Cummings OW, Greenson JK, House MG, Liu X, Nalbantoglu I, Pai R, Davidson DD, Reuss SA (2015) IgG4-related sclerosing cholangitis in the absence of autoimmune pancreatitis mimicking extrahepatic cholangiocarcinoma. Scand J Gastroenterol 50(4):447–453PubMedCrossRef
78.
go back to reference Matsubayashi H, Uesaka K, Sugiura T, Ohgi K, Sasaki K, Ono H (2014) IgG4-related sclerosing cholangitis without obvious pancreatic lesion: difficulty in differential diagnosis. J Dig Dis 15(7):394–403PubMedCrossRef Matsubayashi H, Uesaka K, Sugiura T, Ohgi K, Sasaki K, Ono H (2014) IgG4-related sclerosing cholangitis without obvious pancreatic lesion: difficulty in differential diagnosis. J Dig Dis 15(7):394–403PubMedCrossRef
79.
go back to reference Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, Fukushima M, Nikaido T, Nakayama K, Usuda N, Kiyosawa K (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344(10):732–738PubMedCrossRef Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, Fukushima M, Nikaido T, Nakayama K, Usuda N, Kiyosawa K (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344(10):732–738PubMedCrossRef
80.
go back to reference Kawakami H, Zen Y, Kuwatani M, Eto K, Haba S, Yamato H, Shinada K, Kubota K, Asaka M (2010) IgG4-related sclerosing cholangitis and autoimmune pancreatitis: histological assessment of biopsies from Vater’s ampulla and the bile duct. J Gastroenterol Hepatol 25(10):1648–1655PubMedCrossRef Kawakami H, Zen Y, Kuwatani M, Eto K, Haba S, Yamato H, Shinada K, Kubota K, Asaka M (2010) IgG4-related sclerosing cholangitis and autoimmune pancreatitis: histological assessment of biopsies from Vater’s ampulla and the bile duct. J Gastroenterol Hepatol 25(10):1648–1655PubMedCrossRef
81.
go back to reference Umemura T, Zen Y, Hamano H, Kawa S, Nakanuma Y, Kiyosawa K (2007) Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 46(2):463–471PubMedCrossRef Umemura T, Zen Y, Hamano H, Kawa S, Nakanuma Y, Kiyosawa K (2007) Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 46(2):463–471PubMedCrossRef
82.
go back to reference Hokuto D, Yamato I, Nomi T, Yasuda S, Obara S, Yamada T, Chihiro K, Nakajima Y (2015) Eosinophilic cholangitis coexisted with idiopathic thrombocytopenic purpura: report of a case. Hepatol Res 45(5):595–600PubMedCrossRef Hokuto D, Yamato I, Nomi T, Yasuda S, Obara S, Yamada T, Chihiro K, Nakajima Y (2015) Eosinophilic cholangitis coexisted with idiopathic thrombocytopenic purpura: report of a case. Hepatol Res 45(5):595–600PubMedCrossRef
83.
go back to reference Fragulidis GP, Vezakis AI, Kontis EA, Pantiora EV, Stefanidis GG, Politi AN, Koutoulidis VK, Mela MK, Polydorou AA (2016) Eosinophilic cholangitis-a challenging diagnosis of benign biliary stricture: a case report. Medicine (Baltimore) 95(1):e2394CrossRef Fragulidis GP, Vezakis AI, Kontis EA, Pantiora EV, Stefanidis GG, Politi AN, Koutoulidis VK, Mela MK, Polydorou AA (2016) Eosinophilic cholangitis-a challenging diagnosis of benign biliary stricture: a case report. Medicine (Baltimore) 95(1):e2394CrossRef
84.
go back to reference Leegaard M (1980) Eosinophilic cholecystitis. Acta Chir Scand 146(4):295–296PubMed Leegaard M (1980) Eosinophilic cholecystitis. Acta Chir Scand 146(4):295–296PubMed
85.
go back to reference Butler TW, Feintuch TA, Caine WP Jr (1985) Eosinophilic cholangitis, lymphadenopathy, and peripheral eosinophilia: a case report. Am J Gastroenterol 80(7):572–574PubMed Butler TW, Feintuch TA, Caine WP Jr (1985) Eosinophilic cholangitis, lymphadenopathy, and peripheral eosinophilia: a case report. Am J Gastroenterol 80(7):572–574PubMed
86.
go back to reference Goode EC, Simpson Bw, Rushbrook SM, Rushbrook SM (2013) A rare cause of cholangiopathy. Gastroenterology 144(7):e14–e15PubMedCrossRef Goode EC, Simpson Bw, Rushbrook SM, Rushbrook SM (2013) A rare cause of cholangiopathy. Gastroenterology 144(7):e14–e15PubMedCrossRef
87.
go back to reference Yagawa Y, Yasuda H, Sugimoto M, Koda K, Suzuki M, Yamazaki M, Tezuka T, Kosugi C, Higuchi R, Watayo Y (2008) Two cases of eosinophilic cholangitis caused biliary obstruction. Jpn J Gastroenterol Surg 41(5):533–539CrossRef Yagawa Y, Yasuda H, Sugimoto M, Koda K, Suzuki M, Yamazaki M, Tezuka T, Kosugi C, Higuchi R, Watayo Y (2008) Two cases of eosinophilic cholangitis caused biliary obstruction. Jpn J Gastroenterol Surg 41(5):533–539CrossRef
88.
go back to reference Usuki N, Toyoshima M, Mikami S, Katsuyama E (2011) A case of eosinophilic cholangitis. Jpn J Clin Radiol 56(2):261–264 Usuki N, Toyoshima M, Mikami S, Katsuyama E (2011) A case of eosinophilic cholangitis. Jpn J Clin Radiol 56(2):261–264
89.
90.
go back to reference Platt ML, Kiesling VJ Jr, Vaccaro JA (1990) Eosinophilic ureteritis associated with eosinophilic cholangitis: a case report. J Urol 144(1):127–129PubMed Platt ML, Kiesling VJ Jr, Vaccaro JA (1990) Eosinophilic ureteritis associated with eosinophilic cholangitis: a case report. J Urol 144(1):127–129PubMed
91.
go back to reference Grauer L, Padilla Iii VM, Bouza L, Barkin JS (1993) Eosinophilic sclerosing cholangitis associated with hypereosinophilic syndrome. Am J Gastroenterol 88(10):1764–1769PubMed Grauer L, Padilla Iii VM, Bouza L, Barkin JS (1993) Eosinophilic sclerosing cholangitis associated with hypereosinophilic syndrome. Am J Gastroenterol 88(10):1764–1769PubMed
92.
go back to reference Kroemer A, Sabet-Baktach M, Doenecke A, Ruemmele P, Scherer MN, Schlitt HJ, Breidert M (2012) Eosinophilic cholangitis and wirsungitis as cause of simultaneous bile duct obstruction and pancreatitis. Z Gastroenterol 50(8):766–770PubMedCrossRef Kroemer A, Sabet-Baktach M, Doenecke A, Ruemmele P, Scherer MN, Schlitt HJ, Breidert M (2012) Eosinophilic cholangitis and wirsungitis as cause of simultaneous bile duct obstruction and pancreatitis. Z Gastroenterol 50(8):766–770PubMedCrossRef
93.
go back to reference Rodgers MS, Allen JP, Koea JB, McCall JL (2001) Eosinophilic cholangitis: a case of ‘malignant masquerade’. HPB (Oxford) 3(3):235–239CrossRef Rodgers MS, Allen JP, Koea JB, McCall JL (2001) Eosinophilic cholangitis: a case of ‘malignant masquerade’. HPB (Oxford) 3(3):235–239CrossRef
94.
go back to reference Raptou G, Pliakos I, Hytiroglou P, Papavramidis S, Karkavelas G (2009) Severe eosinophilic cholangitis with parenchymal destruction of the left hepatic lobe due to hydatid disease. Pathol Int 59(6):395–398PubMedCrossRef Raptou G, Pliakos I, Hytiroglou P, Papavramidis S, Karkavelas G (2009) Severe eosinophilic cholangitis with parenchymal destruction of the left hepatic lobe due to hydatid disease. Pathol Int 59(6):395–398PubMedCrossRef
95.
go back to reference Rosengart TK, Rotterdam H, Ranson JHC (1990) Eosinophilic cholangitis: a self-limited cause of extrahepatic biliary obstruction. Am J Gastroenterol 85(5):582–585PubMed Rosengart TK, Rotterdam H, Ranson JHC (1990) Eosinophilic cholangitis: a self-limited cause of extrahepatic biliary obstruction. Am J Gastroenterol 85(5):582–585PubMed
96.
go back to reference Matsumoto N, Yokohama K, Nakai K, Yamamoto T, Otani T, Ogawa M, Tanaka N, Iwasaki A, Arakawa Y, Sugitani M (2007) A case of eosinophilic cholangitis: imaging findings of contrast-enhanced ultrasonography, cholangioscopy, and intraductal ultrasonography. World J Gastroenterol 13(13):1995–1997PubMedPubMedCentralCrossRef Matsumoto N, Yokohama K, Nakai K, Yamamoto T, Otani T, Ogawa M, Tanaka N, Iwasaki A, Arakawa Y, Sugitani M (2007) A case of eosinophilic cholangitis: imaging findings of contrast-enhanced ultrasonography, cholangioscopy, and intraductal ultrasonography. World J Gastroenterol 13(13):1995–1997PubMedPubMedCentralCrossRef
97.
go back to reference Miura F, Asano T, Amano H, Yoshida M, Toyota N, Wada K, Kato K, Takada T, Fukushima J, Kondo F, Takikawa H (2009) Resected case of eosinophilic cholangiopathy presenting with secondary Sclerosing cholangitis. World J Gastroenterol 15(11):1394–1397PubMedPubMedCentralCrossRef Miura F, Asano T, Amano H, Yoshida M, Toyota N, Wada K, Kato K, Takada T, Fukushima J, Kondo F, Takikawa H (2009) Resected case of eosinophilic cholangiopathy presenting with secondary Sclerosing cholangitis. World J Gastroenterol 15(11):1394–1397PubMedPubMedCentralCrossRef
98.
go back to reference Shanti CM, Lucas CE, Tyburski JG, Tyburski JG, Soulen RL, Soulen Rl, Lucas DR (2001) Eosinophilic abscess and eosinophilic pseudotumor presenting as bile duct masses: a report of 2 cases. Surgery 130(1):104–108PubMedCrossRef Shanti CM, Lucas CE, Tyburski JG, Tyburski JG, Soulen RL, Soulen Rl, Lucas DR (2001) Eosinophilic abscess and eosinophilic pseudotumor presenting as bile duct masses: a report of 2 cases. Surgery 130(1):104–108PubMedCrossRef
99.
go back to reference Chen WH, Yu CC, Wu CC, Jan YJ (2009) Eosinophilic cholangitis with obstructive jaundice mimicking bile duct carcinoma. J Hepatobiliary Pancreat Surg 16(2):242–245PubMedCrossRef Chen WH, Yu CC, Wu CC, Jan YJ (2009) Eosinophilic cholangitis with obstructive jaundice mimicking bile duct carcinoma. J Hepatobiliary Pancreat Surg 16(2):242–245PubMedCrossRef
100.
go back to reference Burnett AS, Bailey J, Oliver JB, Ahlawat S, Chokshi RJ (2014) Sensitivity of alternative testing for pancreaticobiliary cancer: a 10-y review of the literature. J Surg Res 190(2):535–547PubMedCrossRef Burnett AS, Bailey J, Oliver JB, Ahlawat S, Chokshi RJ (2014) Sensitivity of alternative testing for pancreaticobiliary cancer: a 10-y review of the literature. J Surg Res 190(2):535–547PubMedCrossRef
101.
go back to reference Takikawa H (1999) Recent status of primary sclerosing cholangitis in Japan. J Hepatobiliary Pancreat Surg 6(4):352–355PubMedCrossRef Takikawa H (1999) Recent status of primary sclerosing cholangitis in Japan. J Hepatobiliary Pancreat Surg 6(4):352–355PubMedCrossRef
102.
go back to reference Iwamuro M, Yamamoto K, Kawamoto H, Terada R, Ogawa T, Nose S (2009) Eosinophilic cholangitis with initial clinical features indistinguishable from IgG4-related cholangitis. Intern Med 48(13):1143–1147PubMedCrossRef Iwamuro M, Yamamoto K, Kawamoto H, Terada R, Ogawa T, Nose S (2009) Eosinophilic cholangitis with initial clinical features indistinguishable from IgG4-related cholangitis. Intern Med 48(13):1143–1147PubMedCrossRef
103.
go back to reference Zen Y, Ishikawa A, Ogiso S, Heaton N, Portmann B (2012) Follicular cholangitis and pancreatitis - clinicopathological features and differential diagnosis of an under-recognized entity. Histopathology 60(2):261–269PubMedCrossRef Zen Y, Ishikawa A, Ogiso S, Heaton N, Portmann B (2012) Follicular cholangitis and pancreatitis - clinicopathological features and differential diagnosis of an under-recognized entity. Histopathology 60(2):261–269PubMedCrossRef
104.
go back to reference Aoki T, Kubota K, Oka T, Hasegawa K, Hirai I, Makuuchi M (2003) Follicular cholangitis: another cause of benign biliary stricture. Hepatogastroenterology 50(51):639–642PubMed Aoki T, Kubota K, Oka T, Hasegawa K, Hirai I, Makuuchi M (2003) Follicular cholangitis: another cause of benign biliary stricture. Hepatogastroenterology 50(51):639–642PubMed
105.
go back to reference Fujii M, Shiode J, Niguma T, Ito M, Ishiyama S, Fujiwara A, Nose S, Yoshioka M, Mimura T (2014) A case of follicular cholangitis mimicking hilar cholangiocarcinoma. Clin J Gastroenterol 7(1):62–67PubMedCrossRef Fujii M, Shiode J, Niguma T, Ito M, Ishiyama S, Fujiwara A, Nose S, Yoshioka M, Mimura T (2014) A case of follicular cholangitis mimicking hilar cholangiocarcinoma. Clin J Gastroenterol 7(1):62–67PubMedCrossRef
106.
go back to reference Mizuuchi Y, Aishima S, Hattori M, Ushijima Y, Aso A, Takahata S, Ohtsuka T, Ueda J, Tanaka M, Oda Y (2014) Follicular pancreatitis, report of a case clinically mimicking pancreatic cancer and literature review. Pathol Res Pract 210(2):118–122PubMedCrossRef Mizuuchi Y, Aishima S, Hattori M, Ushijima Y, Aso A, Takahata S, Ohtsuka T, Ueda J, Tanaka M, Oda Y (2014) Follicular pancreatitis, report of a case clinically mimicking pancreatic cancer and literature review. Pathol Res Pract 210(2):118–122PubMedCrossRef
107.
go back to reference Gupta RK, Xie BH, Patton KT, Lisovsky M, Burks E, Behrman SW, Klimstra D, Deshpande V (2016) Follicular pancreatitis: a distinct form of chronic pancreatitis—an additional mimic of pancreatic neoplasms. Hum Pathol 48:154–162PubMedCrossRef Gupta RK, Xie BH, Patton KT, Lisovsky M, Burks E, Behrman SW, Klimstra D, Deshpande V (2016) Follicular pancreatitis: a distinct form of chronic pancreatitis—an additional mimic of pancreatic neoplasms. Hum Pathol 48:154–162PubMedCrossRef
Metadata
Title
Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma
Authors
Hiep Nguyen Canh
Kenichi Harada
Publication date
01-12-2016
Publisher
Springer Japan
Published in
Medical Molecular Morphology / Issue 4/2016
Print ISSN: 1860-1480
Electronic ISSN: 1860-1499
DOI
https://doi.org/10.1007/s00795-016-0143-6

Other articles of this Issue 4/2016

Medical Molecular Morphology 4/2016 Go to the issue